Multidrug resistance in cancer (Review)

International Journal of Oncology

Volumn 9, Issue 5, 1996, Pages 879-884

  Srivastava, Rakesh K ^a   Srivastava, Aparna R ^b   Cho Chung, Yoon S ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

8 Cl cAMP; cancer; MDR; multidrug resistance; P glycoprotein; PKA; PKC; transcription

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOPROTEIN P; PROTEIN KINASE C;

CANCER; CANCER CHEMOTHERAPY; GENETIC REGULATION; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029860390     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.5.879     Document Type: Review

References (77)

1. Endicott JA and Ling V: The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58: 137-171, 1989.
2. Chin K-V, Pastan I and Gottesman MM: Function and regulation of the human multidrug resistance gene. Adv Cancer Res 60: 157-180, 1993.
3. Bellamy WT and Dalton WS: Multidrug resistance in the laboratory and clinic. Advan Clinical Chem 31: 1-61, 1994.
4. Chan HSL, DeBoer G, Thorner PS, Haddad G, Gallie BL and Ling V: Multidrug resistance: Clinical opportunities in diagnosis and circumvention. New Drug Ther 8: 383-410, 1994.
5. Gottesman MM and Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993.
6. Bellamy WT: The role of glutathione S-transferases in drug resistance. In: Alternative Mechanisms of Multidrug Resistance in Cancer. Kellen JA (ed). Birkhauser, Boston, pp31-65, 1994.
7. Liu LF: DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58: 351-375, 1989.
8. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart EU, Kurz AMV, Duncan AMU and Deeley RG: Identification of a novel ATP binding cassette transporter gene overexpressed in a multidrug resistant human lung cancer cell lines. Science 258: 1650-1654, 1992.
9. Juliano RL and Ling V: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem Acta 455: 152-162, 1976.
10. Devault A and Gros P: Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificity's. Mol Cell Biol 10: 1652-1663, 1990.
11. Gros P, Croop J and Housman D: Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47: 371-380, 1986.
12. Gros P, Raymond M, Bell J and Housman D: Cloning and characterization of a second member of the mouse mdr gene family. Mol Cell Biol 8: 2770-2778, 1988.
13. Chen C-J, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM and Roninson IB: Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from human multidrug-resistant cells. Cell 47: 381-389, 1986.
14. Van Der Bliek AM, Kooiman PM, Schneider C and Borst P: Sequence of mdr3 cDNA encoding a human P-glycoprotein. Gene 71: 401-411, 1988.
15. Higgins CF: ABC transporters: from microorganism to man. Annu Rev Cell Biol 8: 67-113, 1992.
16. Doige CA and Ames GFL: ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance. Annu Rev Microbiol 47: 291-319, 1993.
17. Boscoboinik D, Debane M, Stafford A, Jung C, Gupta R and Epand R: Dimerization of the P-glycoprotein in the membranes. Biochim Biophys Acta 1027: 225-228, 1990.
18. Deuchars KL and Ling V: P-glycoprotein and multidrug resistance in cancer chemotherapy. Semin Oncol 16: 156-166, 1989.
19. Gerlach JR, Bell DR, Karakousis C, Slocum HK, Kartner N, Rustum YM and Baker RM: P-glycoprotein in human sarcoma: evidence for multidrug resistance. J Clin Oncol 5: 1452-1460, 1987.
20. Riordan JR, Deuchars K and Kartner N: Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 316: 817-821, 1985.
21. Ueda K, Carderelli C, Gottesman M and Pastan I: Expression of a full length cDNA for the human mdr1 gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 84: 3004-3008, 1987.
22. Guild BC, Mulligan RC, Gros P and Housman D: Retroviral transfer of a murine DNA for multidrug resistance confers pleiotropic drug resistance to cells without prior drug selection. Proc Natl Acad Sci USA 85: 1595-1599, 1988.
23. Schinkel AH, Roelofs MEM and Borst P: Characterization of the human MDR3 P-glycoprotein and its recognitions by P-glycoprotein-specific monoclonal antibodies. Cancer Res 51: 2628-2635, 1991.
24. Choi K, Chen C-J, Kriegler M and Roninson IB: An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell 53: 519-529, 1988.
25. Higgins CF and Gottesman MM: Is the multidrug transporter a flippase? Trends Biochem Sci 17: 18-21, 1992.
26. Valverde MA, Diaz M, Sepulveda FV, Gill DR, Hyde SC and Higgins CF: Volume-regulated chloride channel association with the human multidrug resistance P-glycoprotein. Nature 355: 830-833, 1992.
27. Gill DR, Hyde SC, Higgins CF, Valverde MA, Mintening GM and Sepulveda FV: Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein. Cell 71: 23-32, 1992.
28. Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arceci RJ, Kramer R, Guidotti G and Cantiello HF: The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc Natl Acad Sci USA 90: 312-316, 1993.
29. - currents in NIH/3T3 cells. Am J Physiol 267: 650-658, 1994.
30. Hardy SP, Goodfellow HR, Valverde MA, Gill DR, Sepulveda FV and Higgins CF: Protein kinase C mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels. EMBO J 14: 68-75, 1995.
31. + channels and volume-regulated anion channels in multidrug-resistance small cell lung cancer cells. Cancer Res 53: 4156-4160, 1993.
32. Pastan I and Gottesman M: Multiple-drug resistance in human cancer. N Engl J Med 316: 1388-1393, 1987.
33. Goldstein IJ, Galski H, Fojo AT, Willingham M, Lai S-L, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM and Pastan I: Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81: 116-124, 1989.
34. Cordon-Cardo C, O'Brien JP, Boccia J, et al: Expresion of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38: 1277-1290, 1990.
35. Beebe SJ and Corbin JD: Cyclic nucleotide-dependent protein kinases. In: The Enzyme: Control by Phosphorylation. Boyer PD and Krebs EG (eds). Academic Press, New York, Vol 17, part A, pp43-111, 1986.
36. Lohmann SM and Walter U: Regulation of the cellular and subcellular concentrations and distribution of cyclic nucleotide-dependent protein kinase. In: Advances in Cyclic Nucleotide and Protein Phosphorylation Research. Greengard P and Robison GA (eds). Raven Press, New York, Vol 18, pp63-117, 1984.
37. Cho-Chung YS: Role of cAMP receptor proteins in growth, differentiation, and suppression of malignancy: New approaches to therapy [Perspectives in cancer research]. Cancer Res 50: 7093-7100, 1990.
38. Mellado W and Horwitz SB: Phosphorylation of the multidrug resistant associated glycoprotein. Biochemistry 26: 6900-6904, 1987.
39. Chambers TC, Pohl J, Glass DB and Kuo JF: Phosphorylation by protein kinase C and cyclic AMP-dependent protein kinase of synthetic peptides derived from the linker region of human P-glycoprotein. Biochem J 299: 309-315, 1994.
40. Rohlff C, Safa B, Rahman A, Cho-Chung YS, Klecker RW and Glazer RI: Reversal of resistance to adriamycin by 8-Chlorocyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-bindig protein DNA-binding activities. Mol Pharmacol 43: 372-379, 1993.
41. Miller WR, Hulme MJ, Cho-Chung YS and Elton RA: Types of cyclic AMP binding proteins in human breast cancers. Eur J Cancer 29A: 989-991, 1993.
42. Abraham I, Chin K-V, Gottesman MM, Mayo JK and Sampson KE: Transfection of a mutant regulatory subunit gene of cAMP-dependent protein kinase causes increased drug sensitivity and decreased expression of P-glycoprotein. Exp Cell Res 189: 133-141, 1990.
43. Chin K-V, Chaukan SS, Abraham I, Sapson KE, Krolczyk AJ, Wong M, Schimmer B, Pastan I and Gottesman MM: Reduced mRNA levels for the multidrug-resistance genes in cAMP-dependent protein kinase mutant cell lines. J Cell Physiol 152: 87-94, 1992.
44. Kim S-H, Park J-I, Cluing BS, Kang C-D and Hidaka H: Inhibition of MDR1 gene expression by H-87, a selective inhibitor of cAMP-dependent protein kinase. Cancer Lett 74: 37-41, 1993.
45. Hunter T and Karin M: The regulation of transport by phosphorylation. Cell 70: 375-387, 1992.
46. Yokozaki H, Budillon A, Clair T, Kelley K, Cowan KH, Rohlff C, Glazer RI and Cho-Chung YS: 8-Chloroadenosine 3′,5′-monophosphate as a novel modulator of multidrug resistance. Int J Oncol 3: 423-430, 1993.
47. Scala S, Budillon A, Zhan Z, Cho-Chung YS, Jefferson J, Tsokos M and Bates SE: Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells. J Clin Invest 96: 1026-1034, 1995.
48. Madden MJ, Morrow CS, Nakagawa M, Goldsmith ME, Fairchild CR and Cowan KH: Identification of 5′ and 3′ sequences involved in the regulation of transcription of the human mdr1 gene in vivo. J Biol Chem 68: 8290-8297, 1993.
49. Bhushan A, Abramson R, Chiu J-F and Tritton TR: Expression of c-fos in human and murine multidrug-resistant cells. Mol Pharmacol 42: 69-74, 1992.
50. Chin K-V, Ueda K, Pastan I and Gottesman MM: Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science 255: 459-462, 1992.
51. Masquiller D and Sassone-Corsi P: Transcriptional cross-talk: Nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by jun. J Biol Chem 267: 22460-22466, 1992.
52. Aoyama N, Nagase T, Sawazaki T, Mizguchi G, Nakagoshi H, Fujisawa J-I, Yoshida M and Ishi S: Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 89: 5403-5407, 1992.
53. Montminy MR, Savarino KA, Wagner JA, Mandel G and Goodman RH: Identification of a cyclic-AMP responsive element within the rat somatostatin gene. Proc Natl Acad Sci USA 83: 6682-6686, 1986.
54. Hod Y and Hanson RW: Cyclic AMP stabilizes the mRNA for phosphoenolpyruvate carboxykinase (GTP) against degradation. J Biol Chem 263: 7747-7752, 1988.
55. Juliani MH, Souza GM and Klein C: cAMP stimulation of Dictyostelium discoideum destabilizes the mRNA for 117 antigen. J Biol Chem 265: 9077-9082, 1990.
56. Ma L, Marquardt D, Takemoto L and Center MS: Analysis of P-glycoprotein phosphorylation in HL-60 cells isolated for resistance to vincristine. J Biol Chem 266: 5593-5599, 1991.
57. Nishizuka Y: The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661-665, 1988.
58. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9: 484-496, 1995.
59. Fine R, Patel J and Chabner B: Phorbol esters induce MDR in human breast cancer cells. Proc Natl Acad Sci USA 85: 582-586, 1988.
60. Aquino A, Hartman KD, Knode MC, Grant S, Huang KP, Niu CH and Glazer RI: Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells. Cancer Res 48: 3324-3329, 1988.
61. O'Brian CA, Fan D, Ward NE, Seid C and Fidler IJ: Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cells. FEBS Lett 246: 78-82, 1989.
62. Tsuruo T, Iida H, Kawabata H, Tsukagoshi S and Sakurai Y: High calcium content of pleiotropic drug-resistant P388 and K562 leukemia and Chinese hamster ovary cells. Cancer Res 44: 5095-5099, 1984.
63. Ido M, Sakurai M, Inagaki M, Saito M and Hidaka H: An inhibitor of protein kinase C 1-(5-isoquinolinylsulfonyl)-2-methypiperazine(H-&) inhibits TPA-induced reduction of vincristine uptake from P388 murine leukemia cells. Leuk Res 10: 1063-1069, 1986.
64. Posada J, McKeegan E, Worthington K, Morin M, Jaken S and Tritton T: Human multidrug resistant KB cells overexpress PKC: Involvement in drug resistance. Cancer Commun 1: 285-292, 1989.
65. Chambers TC, Zheng B and Kuo JF: Regulation of phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug resistant human KB cells. Mol Pharmacol 41: 1008-1015, 1992.
66. Mori T, Takai Y, Minakuchi R, Yu B and Nishizuka Y: Inhibitory action of chlorpromazine, dibucaine, and other phospholipid-interacting drugs on calcium-activated phospholipid-dependent protein kinase. J Biol Chem 255: 8378-8380, 1980.
67. O'Brian CA, Liskamp RM, Solomon DH and Weinstein IB: Inhibition of protein kinase C by tamoxifen. Cancer Res 45: 2462-2465, 1985.
68. O'Brian CA, Ward NE, Liskamp RM, de Bont DB, Earnsest LE, van Boom JH and Fan D: A novel, N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to adriamycin. Invest New Drugs 9: 169-179, 1991.
69. Kessel D: Effects of phorbol esters on doxorubicin transport systems. Biochem Pharmacol 37: 2297-2299, 1988.
70. Dong Z, Ward N, Fan D, Gupta K and O'Brian C: In vitro model for intrinsic drug resistance: effects of PKC activators on the chemosensitivity of cultured human colon cancer cells. Mol Pharmacol 39: 563-569, 1991.
71. O'Brian CA, Fan D, Ward NE, Dong Z, Iwamoto L, Gupta K, Earnsest L and Fidler I: Transient enhancement of MDR by the bile acid deoxycholate in murine fibrosarcoma cells in vitro. Biochem Pharmacol 41: 797-806, 1991.
72. Chambers T, McAvoy E, Jacobs J and Eilon G: PKC phosphorylates P-glycoprotein in MDR human KB carcinoma cells. J Biol Chem 265: 7679-7686, 1990.
73. Bates SE, Lee JS, Dickstein B, Spolyar M and Fojo AT: Differentiation modulation of P-glycoprotein transport by protein kinase inhibition. Biochemistry 32: 9156-9164, 1993.
74. Yu G, Ahmad S, Aquino A, Fairchild CR, Trepel JB, Ohno S, Suzuki K, Tsurou T, Cowan KH and Glazer RI: Transfection with protein kinase Cα confers increased multidrug resistance to MCF-7 cells overexpressing P-glycoprotein. Cancer Commun 3: 181-189, 1991.
75. Ahmad S, Trepel JB, Ohno S, Suzuki K, Tsuruo T and Glazer RI: Role of protein kinase C in the modulation of multidrug resistance: Expression of the atypical γ isoform of protein kinase C does not confer increased resistance to doxorubicin Mol Pharmacol 42: 1004-1009, 1992.
76. Fan D, Fidler IJ, Ward NE, Seid C, Earnest LE, Housey GM and O'Brian CA: Stable expression of a cDNA encoding rat brain protein kinasc Cβ1 confers a multidrug-resistant phenotype on rat fibroblasts. Anticancer Res 12: 661-668, 1992.
77. Ahmad S and Glazer RI: Expression of the antisense cDNA for protein kinase Cγ attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells. Mol Pharmacol 43: 858-862, 1993.